Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -0.04 | |||||
Debt-to-Equity | -18.32 | |||||
Debt-to-EBITDA | 8.1 | |||||
Interest Coverage | 1.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.11 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -53.2 | |||||
3-Year FCF Growth Rate | -1.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 204.11 | |||||
Days Sales Outstanding | 78.5 | |||||
Days Payable | 83.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -29.24 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.87 | |||||
Operating Margin % | 18.49 | |||||
Net Margin % | -1.87 | |||||
FCF Margin % | 10.62 | |||||
ROA % | -0.66 | |||||
ROIC % | 33.44 | |||||
ROC (Joel Greenblatt) % | 56.91 | |||||
ROCE % | 6.07 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 4.09 | |||||
PE Ratio without NRI | 21.12 | |||||
Price-to-Owner-Earnings | 3.63 | |||||
PEG Ratio | 0.64 | |||||
PS Ratio | 0.31 | |||||
Price-to-Free-Cash-Flow | 2.88 | |||||
Price-to-Operating-Cash-Flow | 2.1 | |||||
EV-to-EBIT | 18.92 | |||||
EV-to-EBITDA | 9.73 | |||||
EV-to-Revenue | 2.72 | |||||
EV-to-FCF | 25.54 | |||||
Price-to-Projected-FCF | 0.54 | |||||
Price-to-Median-PS-Value | 0.37 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.42 | |||||
Earnings Yield (Greenblatt) % | 5.28 | |||||
FCF Yield % | 34.73 | |||||
Forward Rate of Return (Yacktman) % | 27.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 8,269.867 | ||
EPS (TTM) (CHF) | 0 | ||
Beta | 0 | ||
Volatility % | 22.22 | ||
14-Day RSI | 0 | ||
14-Day ATR (CHF) | 0 | ||
20-Day SMA (CHF) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (CHF) | 24.11 - 24.11 | ||
Shares Outstanding (Mil) | 355.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bausch Health Companies Inc Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(XSWX:VRX)'s stock price today?
When is next earnings date of Bausch Health Companies Inc(XSWX:VRX)?
Does Bausch Health Companies Inc(XSWX:VRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |